RecruitingNot applicableNCT06933212

Effect of the Mediterranean Diet in Patients Affected by CADASIL and Cerebral Amyloid Angiopathy.

Studying ITM2B amyloidosis

Last synced from ClinicalTrials.gov May 6, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Principal Investigator: Anna Bersano, MD
Intervention: Mediterranean Diet with Extra Virgin Olive Oil(other)
Enrollment: 86 enrolled
Eligibility: 18 years · All sexes
Timeline: 2024 – 2025

Study locations (1)

Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06933212 on ClinicalTrials.gov

← Back to all trials